Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

217 results
Display

Effects of Antiplatelet Agents on Bleeding after Endoscopic Resection of Gastric Tumor

Ahn JY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors to be Considered for a Choice of Antiplatelet Agents

Cho SJ

  • KMID: 2294625
  • J Korean Acad Fam Med.
  • 2006 Jan;27(1):1-6.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Study of Antiaggregatory Effect of Antiplatelet Agents by Platelet Aggregation Test

Lee WY, Roh JK, Cho HI, Lee SB, Myung HJ

  • KMID: 2065894
  • J Korean Neurol Assoc.
  • 1989 Dec;7(2):252-257.
We performed platelet aggregation test in sixty three patients (54 ; cerebral infarction, 9 ; transient ischemic attack) who were randomly treated with aspirin 300mg/day or dipyridamole 150mg/day, singlely or...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Variability of Platelet Reactivity on Antiplatelet Therapy in Neurointervention Procedure

Yi HJ, Hwang G, Lee BH

As more intracranial aneurysms and other cerebrovascular pathologies are treated with neurointervention procedure, thromboembolic events that frequently lead to serious neurological deficit or fatal outcomes are increasing. In order to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dietary Supplements and Postoperative Bleeding

Choi SY, Ye MK

There is a wide variety of dietary supplements on the market that are taken by patients of all walks of life. Unfortunately their use is self-prescribed and patients rarely view...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparative study of triflusal and ticlopidine on anti-platelet aggregatory effect and side effects

Kim HG, Kim JS, Lee MC

  • KMID: 1546747
  • J Korean Neurol Assoc.
  • 1998 Feb;16(1):21-27.
BACKGROUND AND PURPOSE: Platelet aggregation plays an important role in thrombogenesis. Thus antiplatelet agents, such as aspirin and ticlopidine, have been in usage to prevent for recurrent ischemic stroke. Triflusal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antiplate Agents

Chae SC

The role of platelets in atherogenesis, acute coronary syndrome and the development of complications from percutaneous coronary intervention is relatively well known. Until recently, aspirin was the only antiplatelet agent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Perioperative management and monitoring of antiplatelet agents: a focused review on aspirin and P2Y12 inhibitors

Mazzeffi M, Lee K, Taylor B, Tanaka KA

Platelets play pivotal roles in hemostasis as well as pathological arterial thrombosis. The combination of aspirin and a P2Y₁₂ inhibitor has become the mainstay therapy in the ageing population with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Review of the 2018 Asia-Pacific Working Group Consensus on Non-variceal Upper Gastrointestinal Bleeding

Kim JS, Kim BW

Despite recent advances in endoscopic techniques and acid-suppressive therapies, non-variceal upper gastrointestinal bleeding (NVUGIB) is still associated with significant morbidity and mortality. The increased use of dual antiplatelet agents and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Oral antiplatelet agent hypersensitivity and cross-reactivity managed by successful desensitisation

Chin N, Rangamuwa , Mariasoosai R, Carnes J, Thien F

Oral platelet aggregation inhibitors are widely used for the treatment and prevention of cardiovascular diseases, including coronary stent thrombosis. Premature discontinuation following percutaneous coronary intervention would pose a grave risk...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Multiple Combined Oral Platelet Aggregation Inhibitors of Aspirin, Ticlopidine and Cilostazol after PCI

Byun KH, Shim JK, Min SJ, Jeon SJ, Kim JH

BACKGROUND AND OBJECTIVES: Along with intracoronary stenting, medications, such as Ca++ channel blocker, nitric oxide and some platelet aggregation inhibitors, have contributed to the reduction of coronary restenosis. However, restenosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent advances in ischemic stroke management

Yoon CW, Rha JH

There have been recent advances in the hyperacute treatment and secondary prevention of ischemic stroke. Thrombolysis with intravenous tissue plasminogen activator has been approved for a 3 to 4.5 hour...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Inhibitory Effect of Triflusal (Disgren)on the Platelet Aggregation in Healthy Volunteers: Impedance Method with the Whole Blood

Kang S, Chung KH, Kim TY, Ahn S, Ha JW, Rim S, Lee MH, Paek GY, Jang Y

BACKGROUND: Antiplatelet drugs play an important role in the prevention and treatment of coronary artery diseases. Triflusal, an antiplatelet drug structually related to acetylsalicylic acid, selectively inhibits the cyclooxygenase of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Low Dose Enteric-coated Aspirin Alone or Combination with Ticlopidine on Platelet

Jang Y, Park HY, Kwon HM, Kim IJ, Kim JH, Yoon YW, Kim DS, Kim HS, Lee A, Song KS

BACKGROUND: The role of platelet in the pathogenesis of acute coronary syndrome and cerebral thrombosis is well known and the platelet inhibitors are used widely for primary and sccondary prevention...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The anti-thrombotic activity of surfactins

Lim JH, Park BK, Kim MS, Hwang MH, Rhee MH, Park SC, Yun HI

  • KMID: 1090772
  • J Vet Sci.
  • 2005 Dec;6(4):353-355.
Platelet aggregation was inhibited and the density of platelet-rich plasma (PRP) clots was decreased by the preincubation of PRP with surfactins, an acidic lipopeptide of Bacillus subtilis complex BC1212 isolated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Assessment and management of coagulopathy in neurocritical care

Salem AM, Roh D, Kitagawa R, Choi HA, Chang TR

Coagulopathy may be defined as the loss of balance between hemostatic and fibrinolytic processes resulting in excessive bleeding, intravascular thrombosis or abnormalities in coagulation testing. It is frequently encountered across...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment

Joo HJ, Park JY, Hong SJ, Kim KA, Lee SH, Cho JY, Park JH, Yu CW, Lim DS

BACKGROUND/AIMS: Although epigallocatechin-3-gallate (EGCG), which is found in high contents in the dried leaves of green tea, has been reported to have an anti-platelet effect, synergistic effects of EGCG in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Triple Anti-Platelet Therapy (Aspirin, Clopidogrel, and Cilostazol) and Double Anti-Platelet Therapy (Aspirin and Clopidogrel) on Platelet Aggregation in Type 2 Diabetic Patients Undergoing Drug-Eluting Stent Implantation

Yang TH, Kim DI, Kim JY, Kim IH, Kim KH, Han YC, Kim W, Seol SH, Kim SM, Kim DK, Kim DS

BACKGROUND AND OBJECTIVES: Triple anti-platelet therapy may produce more potent inhibition of platelet aggregation in patients undergoing coronary stent implantation. We tested whether this effect could be maintained in diabetic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Does Dual Antiplatelet Therapy Increase the Risk of Peptic Ulcer Disease?

Kim JJ, Kim N

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gastric Submucosal Hematoma after Endoscopic Hemostasis in Patient with Dual Antiplatelet Therapy

Kim T, Kim HU, Song HJ

Intramural hematoma of the gastrointestinal tract is uncommon, with the majority being localized to the esophagus or duodenum. Hematoma of the gastric wall is extremely rare and caused by coagulopathy,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr